Ignatov Tanja, Eggemann Holm, Burger Elke, Costa Serban Dan, Ignatov Atanas
J Cancer Res Clin Oncol. 2016 Feb;142(2):489-95. doi: 10.1007/s00432-015-2060-9.
The survival effect of adjuvant radiotherapy (RT) for vulvar cancer has been poorly investigated.
We performed a multicentre retrospective register study of 257 patients with primary squamous vulvar cancer. The survival effect of adjuvant RT was investigated in two groups of patients, dependent on surgical margins. The outcome measure was overall survival. All statistical tests were two-sided.
Of the 257 patients investigated, 192 had negative resection margins, while positive and/or close surgical margins were observed in 65 cases. Margin status was associated with unfavourable overall survival. The five-year overall survival was 66.1 and 49.2% in patients with negative and positive/close resection margins, respectively. Adjuvant RT directed to the vulva was associated with improved survival in patients with positive/close resection margins but not in patients with negative surgical margins. The 5-year overall survival of patients with positive/close surgical margins without RT was 29%, whereas with RT it increased to 67.6%. Notably, patients with positive/close surgical margins who received RT of the vulva had a 5-year survival rate similar to the patients with negative margins (67.6%). Multivariate analysis adjusted for age, stage of disease, tumour grade and lymph node metastases showed that adjuvant RT significantly reduced the mortality risk in patients with positive/close resection margins (HR 0.36, CI 0.14–0.94, p = 0.038). In the group of patients with negative resection margins, the involvement of lymph nodes was the strongest unfavourable prognostic factor.
Adjuvant RT should be used for patients with positive/close surgical margins to improve their outcome.
外阴癌辅助放疗(RT)的生存效果研究较少。
我们对257例原发性鳞状外阴癌患者进行了一项多中心回顾性登记研究。根据手术切缘情况将患者分为两组,研究辅助放疗的生存效果。观察指标为总生存期。所有统计检验均为双侧检验。
在257例研究患者中,192例手术切缘阴性,65例切缘阳性和/或接近阳性。切缘状态与不良的总生存期相关。手术切缘阴性和阳性/接近阳性患者的五年总生存率分别为66.1%和49.2%。针对外阴的辅助放疗与手术切缘阳性/接近阳性患者的生存率提高相关,但与手术切缘阴性患者无关。手术切缘阳性/接近阳性且未接受放疗患者的5年总生存率为29%,而接受放疗后则升至67.6%。值得注意的是,接受外阴放疗的手术切缘阳性/接近阳性患者的5年生存率与手术切缘阴性患者相似(67.6%)。对年龄、疾病分期、肿瘤分级和淋巴结转移进行多因素分析后显示,辅助放疗显著降低了手术切缘阳性/接近阳性患者的死亡风险(HR 0.36,CI 0.14 - 0.94,p = 0.038)。在手术切缘阴性的患者组中,淋巴结受累是最不利的预后因素。
手术切缘阳性/接近阳性的患者应使用辅助放疗以改善预后。